These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis. Rui K; Zhang Z; Tian J; Lin X; Wang X; Ma J; Tang X; Xu H; Lu L; Wang S Cell Mol Immunol; 2016 May; 13(3):401-8. PubMed ID: 26388237 [TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894 [TBL] [Abstract][Full Text] [Related]
46. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F Front Immunol; 2019; 10():619. PubMed ID: 31001253 [TBL] [Abstract][Full Text] [Related]
47. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis. Ulivieri C; Baldari CT Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168 [TBL] [Abstract][Full Text] [Related]
48. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells. Kiernan CH; Asmawidjaja PS; Fahy N; Witte-Bouma J; Wolvius EB; Brama PAJ; Lubberts E; Farrell E Tissue Eng Part A; 2020 May; 26(9-10):490-502. PubMed ID: 31797740 [TBL] [Abstract][Full Text] [Related]
49. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. Nyirenda MH; Sanvito L; Darlington PJ; O'Brien K; Zhang GX; Constantinescu CS; Bar-Or A; Gran B J Immunol; 2011 Sep; 187(5):2278-90. PubMed ID: 21775683 [TBL] [Abstract][Full Text] [Related]
50. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults. Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754 [TBL] [Abstract][Full Text] [Related]
51. The complexity of the CD4 T-cell responses: old and new T-cell subsets. Del Prete G Parassitologia; 2008 Jun; 50(1-2):9-16. PubMed ID: 18693551 [TBL] [Abstract][Full Text] [Related]
52. Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4 Bolandi Z; Mokhberian N; Eftekhary M; Sharifi K; Soudi S; Ghanbarian H; Hashemi SM Life Sci; 2020 Oct; 259():118218. PubMed ID: 32784057 [TBL] [Abstract][Full Text] [Related]
53. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo. Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237 [TBL] [Abstract][Full Text] [Related]
54. Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3 Yu Y; Valderrama AV; Han Z; Uzan G; Naserian S; Oberlin E Stem Cell Res Ther; 2021 Feb; 12(1):138. PubMed ID: 33597011 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells. Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805 [TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection. Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806 [TBL] [Abstract][Full Text] [Related]
57. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner. Zhou C; Wu XR; Liu HS; Liu XH; Liu GH; Zheng XB; Hu T; Liang ZX; He XW; Wu XJ; Smith LC; Zhang Y; Lan P J Crohns Colitis; 2020 Jun; 14(5):654-668. PubMed ID: 31841595 [TBL] [Abstract][Full Text] [Related]
58. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus. Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L Front Immunol; 2020; 11():233. PubMed ID: 32133007 [TBL] [Abstract][Full Text] [Related]
59. Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance. Hu H; Li H; Li R; Liu P; Liu H J Transl Med; 2024 Jul; 22(1):663. PubMed ID: 39010157 [TBL] [Abstract][Full Text] [Related]
60. T helper subsets & regulatory T cells: rethinking the paradigm in the clinical context of solid organ transplantation. Askar M Int J Immunogenet; 2014 Jun; 41(3):185-94. PubMed ID: 24495112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]